期刊文献+

大肠癌组织中基质金属蛋白酶-9及其抑制物的表达和临床意义 被引量:3

Expression and clinical significance of matrix metailoproteinase and matrix metalloproteinase tissue inhibiting factor-1 in colorectal carcinomas
原文传递
导出
摘要 目的探讨大肠癌组织中基质金属蛋白酶-9(MMP-9)及其抑制物基质金属蛋白酶抑制剂-1(TIMP-1)的表达和临床意义。方法采用PowerVision二步法免疫组织化学染色检测42例大肠癌组织及其癌旁组织中MMP-9和TIMP-1表达情况并分析其与临床病理参数的关系。结果MMP-9在大肠癌组织中表达率明显高于癌旁组织(69.1%与45.2%,P=0.009);TIMP-1在大肠癌组织中表达率明显高于癌旁组织(61.9%与40.5%,P=0.004)。MMP-9的表达与Dukes分期、浸润深度、淋巴结转移正相关(rs=0.429,P=0.005;rs=0.372,P=0.015;rs=0.372,P=0.015);TIMP-1的表达与Dukes分期、浸润深度、淋巴结转移正相关(rs=0.394,P=0.010;rs=0.382,P=0.013;rs=0.382,P=0.013)。MMP-9的表达与TIMP-1的表达呈正相关(rs=0.641,P〈0.001)。结论MMP-9和TIMP-1在大肠癌发生发展中起重要作用,联合检测二者对大肠癌侵袭转移的预测、预后评估及指导合理的综合治疗等具有重要的临床意义。 Objective To investigate the expression and clinicopathological significance of matrix metalloproteinase(MMP-9) and matrix metalloproteinase tissue inhibiting factor-1 (TIMP-1) in eolorectal carcinomas. Methods Immunohistoehemistry (PowerVision method) in the paraffin embedded tissue samples was used to determine MMP-9 and TIMP-1 in 42 eolorectal carcinomas and its adjacent normal colorectal mueosa. The relationship of their expression with some clinicopathological characteristics was analyzed. Results MMP-9 and TIMP-1 were both significantly overexpressed in colorectal carcinomas compared with its adjacent normal colorectal mucosa (69.1% and 61.9% vs. 45.2% and 40.5% ,P = 0.009 and P = 0. 004), and MMP-9 was positively associated with the regional lymph node metastasis, bowel wall invasion and Dukes stage ( rs = 0. 372, P = 0.015 ; L = 0. 372, P = 0. 015 ; rs = 0.429 ,P = 0.005 ). TIMP-1 was positively associated with Dukes stage, bowel wall invasion and regional lymph node metastasis (rs =0.394 ,P =0.010;r, =0.382,P =0.013 ;rs = 0. 382,P =0.013 ). There was a positive correlation between the expression of MMP-9 and TIMP-1 ( rs = 0. 641, P 〈 0. 001 ). Conclusion MMP-9 and TIMP-1 may play a key role in eoloreetal carcinogenesis. Examination of MMP-9 and TIMP-1 expression may have an important significance for evaluating prognosis, predicting of invasion and metastasis and comprehensive therapy.
出处 《中国综合临床》 2009年第2期143-145,共3页 Clinical Medicine of China
基金 唐山市科学技术研究与发展指导计划课题(06134601c-8)
关键词 大肠癌 基质金属蛋白酶-9 组织基质金属蛋白酶抑制因子-1 免疫组织化学 Colorectal carcinoma Matrix metalloproteinase-9 Matrix metalloproteinase tissue inhibiting factor-1 Immunohistochemistry
  • 相关文献

参考文献7

  • 1Curran S, Murray GI. Matrix metalloproteinases:molecular aspects of their roles in tumour invasion and metastasis[J]. Eur J Cancer,2000,36(13):1621-1630.
  • 2袁权利,李华,白净,王毅刚,刘建辉,李岩,杨琳,于柏龙.Runx3基因甲基化与大肠癌发生和转移的关系[J].中国综合临床,2007,23(4):345-347. 被引量:11
  • 3Baker EA, Bergin FG, Leaper DJ. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging[ J]. Br J Surg,2000, 87(9) :1215-1221.
  • 4Moran A, Iniesta P, Garcia-Aranda C, et al. Clinical relevance of MMP-9,MMP-2 ,TIMP-1 and TIMP-2 in colorectal cancer[ J ]. On- col Rep,2005,13( 1 ) :115-120.
  • 5Islekel H, Oktay G,Terzi C, et al. Matrix metalloproteinase-9, -3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer:relationship to clinicopathological variables [ J ]. Cell Biochem Funct, 2007,25 (4) :433-441.
  • 6Joo YE, Seo KS, Kim J,et al. Role of tissue inhibitors of metalloproteinases(TIMPs) in colorectal carcinoma[ J]. J Korean Med Sci, 1999,14(4) :417-423.
  • 7Mook OR, Frederiks WM, Van Noorden CJ. The role of gelatinases in colorectal cancer progression and metastasis [ J ]. Biochim Biophys Acta, 2004,1705 ( 2 ) : 69 -89.

二级参考文献11

  • 1Bangsow C, Rubins N, Glusman G, et al. The runx3 gene-sequence, structure and regulated expression[J]. Gene, 2001,279(2) :221232.
  • 2Zaidi SK, Sullivan AJ, van Wijnen AJ, et al. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites[J]. Proc Nail Acad Sci USA,2002,99(12) :8048-8053.
  • 3Tokumaru Y,Nomoto S,Jeronimo C,et al. Biallelic inactivation of the RIZI gene in human gastric cancer [J]. Oncogene, 2003,22(44) :6954- 6958.
  • 4Kang YK, Kim YI, Kim WH. Allelotype analysis of intrahepatic cholan-giocarcinoma[J]. Mod Pathol,2000,13(6):627-631.
  • 5Fang W , Piao Z, Simon D , et al. Mapping of a minimal deleted region in human hepatocellular carcinoma to Ip36. 13-p36.23 and mutational analysis of the RIZ(PRDM2) gene localized to the region[ J]. Genes Chromosomes Cancer,2000,28 (3) :269-275.
  • 6Ito Y. Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PERP2/CBF [ J ]. Genes Cells, 1999,4(12) :685-696.
  • 7Warren AJ, Bravo J, Williams RL, et al. Structural basis for the heterodimeric interaction between the acute leukaemia-asaociated transcription factors AMLI and CBFbeta[J]. EMBO J, 2000, 19(12) :3004-3015.
  • 8Li QL,Ito K ,Sakakura C,et al. Causal relationship between the loss of RUNX3 expression and gastric cancer [ J ]. Cell,2002,109 (1) :113-124.
  • 9Falnaru O, Woolf E, Lotem J. Runx3 regulates mouse TGF-betamediated dendritic cell function and its absence results in airway inflammation[J]. EMBO J, 2004, 23(4) : 969-979.
  • 10Gayther SA, Barley SJ, Linger L. Mutations truncating the EP300 acetylase in human cancers[ J].t Genet,2000,24(3 ) ,300-303.

共引文献10

同被引文献27

  • 1李浩,陈兢,贺民,惠旭辉,蔡博文,李杨.CD147、MMP-2在人脑胶质瘤中的表达及其与预后的关系[J].四川大学学报(医学版),2007,38(3):396-399. 被引量:8
  • 2Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis[ J]. Eur J Cancer, 2000,36( 13 Spec No) :1621-1630.
  • 3Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis [ J ]. J Natl Cancer Inst, 1997,89 ( 17 ) : 1260-1270.
  • 4Baker EA, Bergin FG, Leaper DJ. Matrix mehtlloproteinases, their tissue inhibitors and colorectal cancer staging[J]. Br J Surg,2000, 87(9) :1215-1221.
  • 5Moran A, Iniesta P, Garcia-Aranda C, et al. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer[J]. Oncol Rep ,2005,13 ( 1 ) : 115-120.
  • 6Curran S, Dundas SR, Buxton J, et al. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies, poor prognosis coloreetal cancers [ J ]. Clin Cancer Res, 2004,10 ( 24 ) : 8229-8234.
  • 7孔英君,孙文学,霍建民,石玉枝.慢性阻塞性肺疾病患者血清基质金属蛋白酶及其抑制因子与细胞黏附因子和血管内皮黏附因子的关系研究[J].中国实用内科杂志,2007,27(16):1294-1296. 被引量:17
  • 8Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group [J]. N Engl J Med,1999,340(25) :1941-1947.
  • 9Mercer PF, Shute JK, Bhowmik A, et al. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation [ J ]. Respir Res,2005,6 : 151.
  • 10Mautino G, Henriquet C, Jaffuel D,et al. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects [ J ]. Am J Respir Crit Care Med, 1999,160 ( 1 ) :324-330.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部